# Efficacy and Safety of XP12B in Women With Menorrhagia

> **NCT00401193** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 304 (actual)

## Conditions studied

- Menorrhagia
- Heavy Menstrual Bleeding

## Interventions

- **DRUG:** Tranexamic acid tablets
- **DRUG:** Tranexamic acid tablets
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT00401193
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401193, "Efficacy and Safety of XP12B in Women With Menorrhagia". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00401193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*